Celexa is an antidepressant medication that can cause serious side effects and can even be fatal if taken in excessive doses. That being said, it is important to understand all the facts about celexa dosage before taking the medication. In this article, we will go over what you need to know about celexa dosage so that you can make an informed decision about your treatment plan. We will discuss the different types of dosages available, the recommended dosages, and tips for managing any adverse reactions. Read on for a comprehensive guide to celexa dosage!
Celexa is an antidepressant that is used to treat major depressive disorder and anxiety disorders. The active ingredient in Celexa is citalopram, which is a selective serotonin reuptake inhibitor (SSRI). Celexa works by increasing the level of serotonin in the brain, which helps to improve mood and relieve symptoms of depression and anxiety. Celexa is available in tablet form and is usually taken once a day, with or without food.
Celexa is a selective serotonin reuptake inhibitor (SSRI), which means it increases the level of serotonin in the brain. Serotonin is a neurotransmitter that helps regulate mood, and increasing its levels can help lift someone out of depression. Celexa is approved by the FDA to treat major depressive disorder in adults.
Celexa (citalopram) is an antidepressant that belongs to a class of drugs called selective serotonin reuptake inhibitors (SSRIs). Celexa is available in tablet and oral suspension form. The recommended starting dose of Celexa for adults with depression is 20 mg once daily. The maximum recommended dose of Celexa is 60 mg per day.
Celexa may be taken with or without food. If you take Celexa with food, try to take it with a meal or snack to avoid an upset stomach. You should take Celexa at the same time each day to maintain an even level of the medication in your body.
It may take several weeks for Celexa to start working. as suddenly stopping can cause withdrawal symptoms such as headache, nausea, vomiting, dizziness, insomnia, and electric shock-like sensations.
Celexa is an antidepressant that belongs to a class of drugs called selective serotonin reuptake inhibitors (SSRIs). SSRIs work by increasing the levels of serotonin in the brain. Serotonin is a neurotransmitter, or chemical messenger, that plays a role in mood and emotion.
nausea
dry mouth
dizziness
fatigue
insomnia
sexual dysfunction
sweating
headache
diarrhea
weight gain or loss
anxiety
agitation
irritability
tremor
confusion
seizures
hyponatremia (low sodium levels in the blood)
Generally, Celexa is a good option for people who have moderate to severe depression. It can also be used to treat anxiety disorders and panic disorder.
Celexa is a drug used to treat depression and other related symptoms, however it is important to understand that the dosage must be tailored to each individual. We hope this guide has provided you with the information you need about Celexa so that you can make an informed decision.
Read more such content on @ Hidoc Dr | Medical Learning App for Doctors
1.
Is It Really Cancer? More Concerns About Accelerated Approval; Metformin and Cancer
2.
Pediatric high-grade gliomas: Research reveals effective targeting with avapritinib
3.
In prostate cancer survivorship, sleep disturbances are underappreciated.
4.
Study shows supervised exercise improves strength, physical performance in patients with advanced breast cancer
5.
a cutting-edge cancer diagnostic tool.
1.
Therapeutic Innovations Through Germline Predisposition in Acute Leukemias and Myeloid Neoplasms
2.
Community Survivorship Networks for Long-Term Cancer Wellness
3.
Neuroendocrine Tumors: Case Study on Diagnosis, Treatment Strategies & Patient Management
4.
Targeted Therapies for Breast Cancer: What’s New?
5.
Integrated Insights in Hematology and Quality Improvement
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
2.
Hands-on Workshop: Hematology
3.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
4.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III
5.
Learning About Different Treatment Approaches For Acute Lymphoblastic Leukemia
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation